CALLABLE MULTI DEFENDER VONTI - DOCMORRIS/ROCHE GS/SPIN-OFF BASKET (1 X NOVARTIS AG + 0,2 X SAND... Stock

Certificat

RMAXSV

CH1315859798

Market Closed - Bid/Ask 11:20:01 2024-05-08 EDT Pre-market 02:03:02
98.8 CHF -3.04% Intraday chart for CALLABLE MULTI DEFENDER VONTI - DOCMORRIS/ROCHE GS/SPIN-OFF BASKET (1 X NOVARTIS AG + 0,2 X SAND... 98.1 -0.71%
Current month-1.89%
1 month-4.08%
Date Price Change Volume
24-05-08 98.8 -3.04% 0
24-05-07 101.9 -0.10% 0
24-05-06 102 +1.39% 0

Delayed Quote Swiss Exchange

Last update May 08, 2024 at 11:20 am

More quotes

Static data

Product typeReverse Convertibles
Buy / SellCALL
Underlying ROCHE HOLDING AG
IssuerLogo Issuer Vontobel Vontobel
RMAXSV
ISINCH1315859798
Date issued 2024-02-23
Strike 232.4 CHF
Maturity 2025-02-24 (288 Days)
Parity 0.23 : 1
Emission price 100 CHF
Emission volume N/A
Settlement both
Currency CHF

Technical Indicators

Highest since issue 103.5 CHF
Lowest since issue 96 CHF
Spread 8 CHF
Spread %0.81%

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
225.1 CHF
Average target price
279.4 CHF
Spread / Average Target
+24.12%
Consensus
  1. Stock Market
  2. Certificates
  3. RMAXSV Certificat
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW